These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31853514)

  • 1. Cross-reactivity with Brazilian strains of
    Trzewikoswki de Lima G; Portilho AI; De Gaspari E
    Ther Adv Vaccines Immunother; 2019; 7():2515135519894825. PubMed ID: 31853514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of intranasal and subcutaneous route of immunization in neonatal mice using DODAB-BF as adjuvant with outer membrane vesicles of Neisseria meningitis B.
    de Oliveira Santos FA; Lincopan N; De Gaspari E
    Immunobiology; 2018 Dec; 223(12):750-760. PubMed ID: 30055864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of antigens from outer membrane vesicles of
    Rinaldi FM; Gaspar EB; Brito LT; Gaspari E
    Clin Exp Vaccine Res; 2021 May; 10(2):106-122. PubMed ID: 34222123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outer membrane vesicles (OMVs) and detoxified lipooligosaccharide (dLOS) obtained from Brazilian prevalent N. meningitidis serogroup B strains protect mice against homologous and heterologous meningococcal infection and septic shock.
    Jessouroun E; da Silveira IF; Larangeira AP; Pereira S; Fernandes SA; Rabinovitch L; Frasch CE; Castro-Faria-Neto HC; Bozza PT
    Vaccine; 2004 Jun; 22(20):2617-25. PubMed ID: 15193387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune responses of meningococcal B outer membrane vesicles in middle-aged mice.
    Trzewikoswki de Lima G; Rodrigues TS; Portilho AI; Correa VA; Gaspar EB; De Gaspari E
    Pathog Dis; 2020 Jul; 78(5):. PubMed ID: 32639524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deletion of major porins from meningococcal outer membrane vesicle vaccines enhances reactivity against heterologous serogroup B Neisseria meningitidis strains.
    Matthias KA; Reveille A; Connolly KL; Jerse AE; Gao YS; Bash MC
    Vaccine; 2020 Feb; 38(10):2396-2405. PubMed ID: 32037226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of different routes of immunization using outer membrane vesicles of Neisseria meningitidis B and comparison of two adjuvants.
    Brito LT; Rinaldi FM; Gaspar EB; Correa VA; Gonçalves CA; Portilho AI; Trzewikoswki de Lima G; De Gaspari E
    Vaccine; 2020 Nov; 38(48):7674-7682. PubMed ID: 33082014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
    Gorringe AR; Taylor S; Brookes C; Matheson M; Finney M; Kerr M; Hudson M; Findlow J; Borrow R; Andrews N; Kafatos G; Evans CM; Read RC
    Clin Vaccine Immunol; 2009 Aug; 16(8):1113-20. PubMed ID: 19553555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
    Finney M; Vaughan T; Taylor S; Hudson MJ; Pratt C; Wheeler JX; Vipond C; Feavers I; Jones C; Findlow J; Borrow R; Gorringe A
    Hum Vaccin; 2008; 4(1):23-30. PubMed ID: 17921703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and characterization of a new monoclonal antibody against Neisseria meningitidis: study of the cross-reactivity with different bacterial genera.
    De Gaspari EN
    Hybridoma; 2000 Dec; 19(6):445-53. PubMed ID: 11152396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic Similarity of Gonococcal Homologs to Meningococcal Outer Membrane Proteins of Serogroup B Vaccine.
    Marjuki H; Topaz N; Joseph SJ; Gernert KM; Kersh EN; ; Wang X
    mBio; 2019 Sep; 10(5):. PubMed ID: 31506309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncated Core/NS3 Fusion Protein of HCV Adjuvanted with Outer Membrane Vesicles of Neisseria meningitidis Serogroup B: Potent Inducer of the Murine Immune System.
    Hekmat S; Sadat SM; Aslani MM; Mahdavi M; Bolhassani A; Asgar Halvaee F; Ghahari SMM; Aghasadeghi MR; Siadat SD
    Iran Biomed J; 2019 Jul; 23(4):235-45. PubMed ID: 30278608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of recombinant lipidated P2086 protein as a vaccine candidate for group B Neisseria meningitidis in a murine nasal challenge model.
    Zhu D; Zhang Y; Barniak V; Bernfield L; Howell A; Zlotnick G
    Infect Immun; 2005 Oct; 73(10):6838-45. PubMed ID: 16177362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of heterologous antigens in commensal Neisseria spp.: preservation of conformational epitopes with vaccine potential.
    O'dwyer CA; Reddin K; Martin D; Taylor SC; Gorringe AR; Hudson MJ; Brodeur BR; Langford PR; Kroll JS
    Infect Immun; 2004 Nov; 72(11):6511-8. PubMed ID: 15501782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with meningococcal outer-membrane protein vesicles containing lipooligosaccharide protects mice against lethal experimental group B Neisseria meningitidis infection and septic shock.
    Quakyi EK; Frasch CE; Buller N; Tsai CM
    J Infect Dis; 1999 Sep; 180(3):747-54. PubMed ID: 10438363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dioctadecyldimethylammonium bromide (DODAB-BF) as a new adjuvant for maternal-fetal immunization in mice against Neisseria meningitidis: evaluation of humoral response.
    de Almeida AF; De Gaspari E
    Pathog Dis; 2018 Feb; 76(1):. PubMed ID: 29293977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.
    Gerritzen MJH; Salverda MLM; Martens DE; Wijffels RH; Stork M
    Vaccine; 2019 Nov; 37(47):6978-6986. PubMed ID: 31383485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against infection with Neisseria meningitidis group B serotype 2b by passive immunization with serotype-specific monoclonal antibody.
    Brodeur BR; Larose Y; Tsang P; Hamel J; Ashton F; Ryan A
    Infect Immun; 1985 Nov; 50(2):510-6. PubMed ID: 3932211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The serogroup B meningococcal outer membrane vesicle-based vaccine 4CMenB induces cross-species protection against Neisseria gonorrhoeae.
    Leduc I; Connolly KL; Begum A; Underwood K; Darnell S; Shafer WM; Balthazar JT; Macintyre AN; Sempowski GD; Duncan JA; Little MB; Rahman N; Garges EC; Jerse AE
    PLoS Pathog; 2020 Dec; 16(12):e1008602. PubMed ID: 33290434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and antigenic heterogeneity of a human transferrin-binding protein in Neisseria meningitidis.
    Ferron L; Ferreiros CM; Criado MT; Pintor M
    Infect Immun; 1992 Jul; 60(7):2887-92. PubMed ID: 1612755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.